Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5. [electronic resource]
Producer: 20010823Description: 231-9 p. digitalISSN:- 0818-9641
- Animals
- Cell Survival -- drug effects
- Cell Transplantation -- methods
- Cells, Cultured
- Complement C3 -- immunology
- Complement C5 -- immunology
- Complement Inactivator Proteins -- pharmacology
- Elapid Venoms -- pharmacology
- Female
- Humans
- Immunohistochemistry
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Inbred DBA
- Muscle, Skeletal -- cytology
- Muscular Dystrophy, Duchenne -- therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.